Nature of the Disclosure
This is a regulatory filing pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains the outcome of the Board of Directors meeting held on 11th November 2026, where the un-audited standalone financial results for the quarter and half year ended 30th September 2026 were approved. The document includes the financial statements, segment reporting, a cash flow statement, and an independent auditor's limited review report.
Key Financial Figures (Quarter Ended 30.09.2026)
- Total Income: ₹48,073.35 lakhs (₹480.73 crore)
- Revenue from Operations: ₹47,221.06 lakhs (₹472.21 crore)
- Profit Before Tax (PBT): ₹10,375.20 lakhs (₹103.75 crore)
- Total Tax Expense: ₹2,678.59 lakhs (₹26.79 crore)
- Profit for the Period: ₹7,696.61 lakhs (₹76.97 crore)
- Basic and Diluted Earnings Per Share (EPS): ₹70.34
Key Financial Figures (Half Year Ended 30.09.2026)
- Total Income: ₹91,938.27 lakhs (₹919.38 crore)
- Revenue from Operations: ₹90,311.91 lakhs (₹903.12 crore)
- Profit Before Tax (PBT): ₹19,528.98 lakhs (₹195.29 crore)
- Total Tax Expense: ₹4,923.79 lakhs (₹49.24 crore)
- Profit for the Period: ₹14,605.19 lakhs (₹146.05 crore)
- Basic and Diluted Earnings Per Share (EPS): ₹133.48
Comparative Performance
Quarterly (Q2 FY27 vs Q2 FY26):
- Revenue from Operations increased by 20.9% from ₹39,073.87 lakhs to ₹47,221.06 lakhs.
- Profit Before Tax (PBT) increased by 33.2% from ₹7,789.20 lakhs to ₹10,375.20 lakhs.
- Profit for the Period increased by 30.8% from ₹5,886.14 lakhs to ₹7,696.61 lakhs.
- EPS increased from ₹53.79 to ₹70.34.
Half Yearly (H1 FY27 vs H1 FY26):
- Revenue from Operations increased by 18.2% from ₹76,433.24 lakhs to ₹90,311.91 lakhs.
- Profit Before Tax (PBT) increased by 26.6% from ₹15,427.45 lakhs to ₹19,528.98 lakhs.
- Profit for the Period increased by 25.8% from ₹11,608.72 lakhs to ₹14,605.19 lakhs.
- EPS increased from ₹106.09 to ₹133.48.
Segment-Wise Performance (Quarter Ended 30.09.2026)
- Healthcare Segment Revenue: ₹44,856.25 lakhs | Segment Result (PBIT): ₹11,330.89 lakhs
- Education Segment Revenue: ₹2,407.20 lakhs | Segment Result (PBIT): ₹565.34 lakhs
Assets and Liabilities (as of 30.09.2026)
- Total Assets: ₹2,22,438.36 lakhs (₹2,224.38 crore), increased from ₹2,06,608.11 lakhs on 31.03.2026.
- Property, Plant and Equipment: ₹1,51,280.08 lakhs
- Capital Work-In Progress: ₹18,247.76 lakhs
- Total Equity: ₹1,45,184.61 lakhs (₹1,451.85 crore)
- Total Borrowings (Non-Current + Current): ₹34,483.70 lakhs (₹28,956.87 + ₹5,526.83)
Cash Flow (Half Year Ended 30.09.2026)
- Net Cash from Operating Activities: ₹23,923.32 lakhs
- Net Cash used in Investing Activities: ₹(16,975.52) lakhs (primarily Purchase of PPE & CWIP: ₹18,290.78 lakhs)
- Net Cash used in Financing Activities: ₹(5,507.58) lakhs (primarily repayment of borrowings and lease liabilities, and finance cost paid)
- Net increase in cash and cash equivalents: ₹1,440.22 lakhs
Contingent Liability Disclosure
The Company received an Adjudication Order dated October 27, 2026, from the Joint Commissioner of Customs (Air Cargo), Chennai, concerning an import of machinery matter from 1988. The order determines a payable amount of ₹2.11 crores plus applicable interest, estimated to be around ₹10 crores. The Company is evaluating the order and has made no provision in its books of accounts for this contingent liability.
Other Disclosures
- The financial results have been reviewed by the Audit Committee and approved by the Board.
- The Company does not have any Subsidiary/Associate/Joint Venture, making consolidated results not applicable.
- The Limited Review Report was issued by VKS Aiyer & Co., Chartered Accountants (Firm Regn. No.0000665).
- The Board meeting commenced at 4:38 PM and concluded at 5:43 PM on 11th November 2026.